Cargando…

PTPRA Phosphatase Regulates GDNF-Dependent RET Signaling and Inhibits the RET Mutant MEN2A Oncogenic Potential

The RET proto-oncogene encodes receptor tyrosine kinase, expressed primarily in tissues of neural crest origin. De-regulation of RET signaling is implicated in several human cancers. Recent phosphatome interactome analysis identified PTPRA interacting with the neurotrophic factor (GDNF)-dependent RE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Leena, Pietilä, Elina, Öhman, Tiina, Liu, Xiaonan, Mahato, Arun K., Sidorova, Yulia, Lehti, Kaisa, Saarma, Mart, Varjosalo, Markku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021549/ https://www.ncbi.nlm.nih.gov/pubmed/32062451 http://dx.doi.org/10.1016/j.isci.2020.100871

Ejemplares similares

Zebrafish GDNF and its co-receptor GFRα1 activate the human RET receptor and promote the survival of dopaminergic neurons in vitro
por: Saarenpää, Tuulia, et al.
Publicado: (2017)

RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer
por: Mahato, Arun Kumar, et al.
Publicado: (2020)

Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats
por: Renko, Juho-Matti, et al.
Publicado: (2021)

A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat
por: Sidorova, Yulia A., et al.
Publicado: (2017)

GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential
por: Mulligan, Lois M.
Publicado: (2019)

Acute stress disrupts intestinal homeostasis via GDNF‐RET
por: Lin, Lin, et al.
Publicado: (2020)

RET-independent signaling by GDNF ligands and GFRα receptors
por: Ibáñez, Carlos F., et al.
Publicado: (2020)

Novel RET agonist for the treatment of experimental neuropathies
por: Viisanen, Hanna, et al.
Publicado: (2020)

Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson’s disease
por: Mahato, Arun Kumar, et al.
Publicado: (2020)

Small-Molecule Ligands as Potential GDNF Family Receptor Agonists
por: Ivanova, Larisa, et al.
Publicado: (2018)

Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.
por: Santoro, M., et al.
Publicado: (1993)

The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system
por: Kramer, Edgar R.
Publicado: (2015)

Biphasic functions for the GDNF-Ret signaling pathway in chemosensory neuron development and diversification
por: Donnelly, Christopher R., et al.
Publicado: (2018)

Opposing Spatially Segregated Function of Endogenous GDNF-RET Signaling in Cocaine Addiction
por: Garton, Daniel R., et al.
Publicado: (2023)

A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions
por: Estrada-Zuniga, Cynthia M., et al.
Publicado: (2022)

DNA Topoisomerases Participate in Fragility of the Oncogene RET
por: Dillon, Laura W., et al.
Publicado: (2013)

Alterations of RET, Oncogene in Human Adrenal Tumors
por: Lin, Shiu‐Ru, et al.
Publicado: (1998)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

Roles of the RET Proto-oncogene in Cancer and Development
por: Takahashi, Masahide, et al.
Publicado: (2020)

Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis
por: Lu, Benson, et al.
Publicado: (2009)

Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection
por: Huang, Qin, et al.
Publicado: (2020)

c-RET Molecule in Malignant Melanoma from Oncogenic RET-Carrying Transgenic Mice and Human Cell Lines
por: Ohshima, Yuichiro, et al.
Publicado: (2010)

Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
por: Drinkut, Anja, et al.
Publicado: (2016)

Bimodal regulation of axonal transport by the GDNF-RET signalling axis in healthy and diseased motor neurons
por: Rhymes, Elena R., et al.
Publicado: (2022)

GDNF Increases Inhibitory Synaptic Drive on Principal Neurons in the Hippocampus via Activation of the Ret Pathway
por: Mikroulis, Apostolos, et al.
Publicado: (2022)

GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson’s Disease
por: Renko, Juho-Matti, et al.
Publicado: (2020)

Hair graying with aging in mice carrying oncogenic RET
por: Iida, Machiko, et al.
Publicado: (2020)

Distribution of RET proto‐oncogene variants in children with appendicitis
por: Schultz, Jurek, et al.
Publicado: (2022)

Precision therapy for RET-altered cancers with RET inhibitors
por: Thein, Kyaw Z., et al.
Publicado: (2021)

RET kinase inhibitors for RET-altered thyroid cancers
por: Vodopivec, Danica M., et al.
Publicado: (2022)

RET signaling pathway and RET inhibitors in human cancer
por: Regua, Angelina T., et al.
Publicado: (2022)

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies
por: Solomon, Benjamin J., et al.
Publicado: (2020)

The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations
por: Kinnunen, Matias, et al.
Publicado: (2023)

The RET–Glial Cell-derived Neurotrophic Factor (GDNF) Pathway Stimulates Migration and Chemoattraction of Epithelial Cells
por: Tang, Ming-Jer, et al.
Publicado: (1998)

Correction to: Ret is essential to mediate GDNF’s neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
por: Drinkut, Anja, et al.
Publicado: (2018)

GDNF regulates lipid metabolism and glioma growth through RET/ERK/HIF-1/SREBP-1
por: Yu, Zhi-Yun, et al.
Publicado: (2022)

Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization
por: Schmutzler, Brian S, et al.
Publicado: (2011)

Selective RET kinase inhibition for patients with RET-altered cancers
por: Subbiah, V, et al.
Publicado: (2018)

Biological Activity In Vitro, Absorption, BBB Penetration, and Tolerability of Nanoformulation of BT44:RET Agonist with Disease-Modifying Potential for the Treatment of Neurodegeneration
por: Haider, Malik Salman, et al.
Publicado: (2022)

Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase
por: Moccia, Marialuisa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_std99qufkngn06qq8khtvlm1ci